Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 201–300 of 1,011
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Ozeri-Galai, E., Lebofsky, R., Rahat, A., Bester, A. C., Bensimon, A., & Kerem, B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.019 · Cited by 174
Self-citationThe Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185
“Besides the “wear and tear damage” during normal aging, there are various stress factors that could directly induce the damage of DNA, such as oxidative stress, ultraviolet (UV) or gamma irradiation [52, 53], chemotherapeutics [54], and hyperproliferation caused by the Ras oncogene [55].”
BackgroundLipid (per) oxidation in mitochondria: an emerging target in the ageing process?
Ademowo, O. S., Dias, H. K. I., Burton, D. G. A., & Griffiths, H. R. (2017) · Biogerontology · doi:10.1007/s10522-017-9710-z · Cited by 184
“Cells become senescent in response to various stress-inducing stimuli such as ROS, telomere dysfunction and oncogene activation, which consequently initiates a persistent DNA damage response (DDR) (Di Micco et al. 2006; Rodier et al. 2009; Rossiello et al. 2014).”
BackgroundTumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
Reimann, M., Lee, S., Loddenkemper, C., Dörr, J. R., Tabor, V., Aichele, P., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.043 · Cited by 184
Stable Cellular Senescence Is Associated with Persistent DDR Activation
Fumagalli, M., Rossiello, F., Mondello, C., & d’Adda di Fagagna, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110969 · Cited by 183
“Immunoblotting Cells were lysed in sample buffer and 50 mg of whole cell lysate were resolved by SDS-PAGE, transferred to nitrocellulose and probed as in [21].”
BackgroundMethodSelf-citationATR signaling can drive cells into senescence in the absence of DNA breaks
Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R., & Fernandez-Capetillo, O. (2008) · Genes & Development · doi:10.1101/gad.452308 · Cited by 183
“Recent data have suggested that oncogene-induced senescence is linked to an activation of the DDR due to the generation of “replicative stress” (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundAdams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
Schoppy, D. W., Ragland, R. L., Gilad, O., Shastri, N., Peters, A. A., Murga, M., Fernandez-Capetillo, O., Diehl, J. A., & Brown, E. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58928 · Cited by 182
Senescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 171
Maya-Mendoza, A., Ostrakova, J., Kosar, M., Hall, A., Duskova, P., Mistrik, M., Merchut-Maya, J. M., Hodny, Z., Bartkova, J., Christensen, C., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 176
Regulation of E2Fs and senescence by PML nuclear bodies
Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.-F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.-M., & Ferbeyre, G. (2011) · Genes & Development · doi:10.1101/gad.1975111 · Cited by 177
Burrows, A. E., Smogorzewska, A., & Elledge, S. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009559107 · Cited by 172
“This program is also engaged in response to activated oncogenes, and DNA damage is thought to be the unifying theme among the stimuli that have been shown to induce a senescence phenotype (1, 2).”
BackgroundDNA repair deficiency as a therapeutic target in cancer
Martin, S. A., Lord, C. J., & Ashworth, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.016 · Cited by 177
Regulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
“Spontaneous activation of various oncogenes can result in oncogene-induced senescence [11], a form characterized by proliferative bursts and DNA-hyper replication that engage a sustained DDR signaling [12].”
BackgroundPR-Set7–dependent lysine methylation ensures genome replication and stability through S phase
Tardat, M., Murr, R., Herceg, Z., Sardet, C., & Julien, E. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706179 · Cited by 169
“Given the importance of deregulated DNA replication in tumorigenesis (Bartkova et al., 2006; Di Micco et al., 2006) and that loss of H4-K20me3 patterns are observed in almost all human cancers (Fraga et al., 2005), it will be interesting to explore whether PR-Set7 is a putative target for cellular…”
BackgroundBartkova, J., Hamerlik, P., Stockhausen, M.-T., Ehrmann, J., Hlobilkova, A., Laursen, H., Kalita, O., Kolar, Z., Poulsen, H. S., Broholm, H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.249 · Cited by 171
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
Beck, H., Nähse, V., Larsen, M. S. Y., Groth, P., Clancy, T., Lees, M., Jørgensen, M., Helleday, T., Syljuåsen, R. G., & Sørensen, C. S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905059 · Cited by 169
“Furthermore, oncogenes can induce lesions at replica tion forks, and subsequent induction of the DNA damage response occurs early during tumorigenesis and has been proposed to act as a barrier to tumor progression (Bartkova et al., 2006; Di Micco et al., 2006).”
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904105 · Cited by 172
“…that DDRs triggered by hyper–cell proliferation play a key role or roles in the onset of oncogene-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we next asked whether DDR triggered by hyper–cell proliferation might be involved in the reduction of…”
The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging
Ghosh, K., & Capell, B. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.621 · Cited by 160
“In a seminal study employing human foreskin fibroblasts and mammary epithelial cells, Di Micco et al. (2006) demonstrated that expression of oncogenic HRasV12 leads to oncogene-induced senescence in a DDR and DNA replicationdependent manner, as cells are unable to induce the DDR when DNA…”
BackgroundTao, Y., Kang, B., Petkovich, D. A., Bhandari, Y. R., In, J., Stein-O'Brien, G., Kong, X., Xie, W., Zachos, N., Maegawa, S., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.005 · Cited by 170
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development
Hu, L., Li, H., Zi, M., Li, W., Liu, J., Yang, Y., Zhou, D., Kong, Q.-P., Zhang, Y., & He, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.822816 · Cited by 160
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Kleiblova, P., Shaltiel, I. A., Benada, J., Ševčík, J., Pecháčková, S., Pohlreich, P., Voest, E. E., Dundr, P., Bartek, J., Kleibl, Z., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210031 · Cited by 170
“…identified oncogene-induced replication stress and DNA breakage that trigger the DDR as an intrinsic barrier against progression of early preinvasive stages of solid tumors to malignant lesions (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005; Di Micco et al., 2006; Halazonetis et al., 2008).”
SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation
Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., & Motoyama, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116480 · Cited by 170
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence
Nakamura, A. J., Chiang, Y. J., Hathcock, K. S., Horikawa, I., Sedelnikova, O. A., Hodes, R. J., & Bonner, W. M. (2008) · Epigenetics & Chromatin · doi:10.1186/1756-8935-1-6 · Cited by 168
“However, there is considerable evidence that cellular senescence and organismal aging can occur through mechanisms other than telomere dysfunction [15-17].”
BackgroundLe, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
“…telomere attrition ⁄ dysfunction (d’Adda di Fagagna et al., 2003; Herbig et al., 2006) and telomere-independent mechanisms such as oxidative stress or the expression of certain oncogenes (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007; Matheu et al., 2007; Wang et al., 2009).”
BackgroundOxidative stress, cellular senescence and ageing
Pole, A., Department of Biochemistry and Molecular Medicine, S. O. M. A. H. S., Dimri, M., & P. Dimri, G. (2016) · AIMS Molecular Science · doi:10.3934/molsci.2016.3.300 · Cited by 155
“These reagents and other stressors including activated oncogenes such as H-Ras generates ROS [88], which lead to DNA damage response (DDR) and induction of cellular senescence [89,90].”
BackgroundInfluentialNucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
Genomic instability, inflammatory signaling and response to cancer immunotherapy
Chen, M., Linstra, R., & van Vugt, M. A. T. M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188661 · Cited by 166
mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Jung, S. H., Hwang, H. J., Kang, D., Park, H. A., Lee, H. C., Jeong, D., Lee, K., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2019) · Oncogene · doi:10.1038/s41388-018-0521-8 · Cited by 166
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165
Reorganization of chromosome architecture in replicative cellular senescence
Criscione, S. W., De Cecco, M., Siranosian, B., Zhang, Y., Kreiling, J. A., Sedivy, J. M., & Neretti, N. (2016) · Science Advances · doi:10.1126/sciadv.1500882 · Cited by 164
Bartkova, J., Tommiska, J., Oplustilova, L., Aaltonen, K., Tamminen, A., Heikkinen, T., Mistrik, M., Aittomäki, K., Blomqvist, C., Heikkilä, P., et al. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.09.007 · Cited by 158
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
Dreyer, S. B., Upstill-Goddard, R., Paulus-Hock, V., Paris, C., Lampraki, E.-M., Dray, E., Serrels, B., Caligiuri, G., Rebus, S., Plenker, D., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.043 · Cited by 163
Rossiello, F., Herbig, U., Longhese, M. P., Fumagalli, M., & d’Adda di Fagagna, F. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.009 · Cited by 156
Self-citationStrozyk, E., & Kulms, D. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815260 · Cited by 160
“Thus, senescence represents a physiological anti-tumor response [113–116].”
BackgroundBorghi, L., Gutzat, R., Fütterer, J., Laizet, Y., Hennig, L., & Gruissem, W. (2010) · The Plant Cell · doi:10.1105/tpc.110.074591 · Cited by 159
Tumour Cell Secretome in Chemoresistance and Tumour Recurrence
Madden, E. C., Gorman, A. M., Logue, S. E., & Samali, A. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.02.020 · Cited by 159
Tsantoulis, P. K., Kotsinas, A., Sfikakis, P. P., Evangelou, K., Sideridou, M., Levy, B., Mo, L., Kittas, C. N., Wu, X., Papavassiliou, A. G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210989 · Cited by 176
“The sequence of these events was triggered by oncogenic stimuli, and was collectively defined as oncogene-induced replication stress (RS) (Bartkova et al., 2005, 2006; Gorgoulis et al., 2005; DiMicco et al., 2006).”
BackgroundInfluentialTelomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 172
MLL1 is essential for the senescence-associated secretory phenotype
Capell, B. C., Drake, A. M., Zhu, J., Shah, P. P., Dou, Z., Dorsey, J., Simola, D. F., Donahue, G., Sammons, M., Rai, T. S., et al. (2016) · Genes & Development · doi:10.1101/gad.271882.115 · Cited by 156
Yu, Y., Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M. R., Qutob, N., van Rooijen, E., Werner-Klein, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.002 · Cited by 156
“…blocker hydroxyurea prevented H3R9 replacement in senescent cells (Figure S3B), we consider the possibility that histone H3 turnover in senescence is, at least in part, coupled to continuous but abortive DNA replication attempts that fail at stalled replication forks (Di Micco et al., 2006).”
BackgroundNeubauer, A., Maharry, K., Mrózek, K., Thiede, C., Marcucci, G., Paschka, P., Mayer, R. J., Larson, R. A., Liu, E. T., & Bloomfield, C. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.0418 · Cited by 158
“Recent studies provide experimental evidence that mutated RAS not only induces proliferation, apoptosis, senescence, or differentiation (depending on the cellular context in which it is expressed),(31) but it may also induce a DNA damage checkpoint response.(32-34) These results provide biologic plausibility to our cl…”
ResultJia, L., Li, H., & Sun, Y. (2011) · Neoplasia · doi:10.1593/neo.11420 · Cited by 155
“Moreover, two phosphorylated proteins, pCHK1 and pH2AX, reflecting the cellular DNA damage response, which is a potential trigger of cell senescence [25,26], also remained at the elevated levels on drug removal (Figure 6C).”
BackgroundCellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 171
“The disruption of DNA damage response factors, ATM and Chk2, prevents oncogene-induced senescence and promotes cellular transformation in vitro, and Chk2−/− mice show increased susceptibility to mutagen-induced skin tumors in vivo (Hirao et al. 2002; Di Micco et al. 2006).”
Inflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Age‐associated increase in heterochromatic marks in murine and primate tissues
Kreiling, J. A., Tamamori‐Adachi, M., Sexton, A. N., Jeyapalan, J. C., Munoz‐Najar, U., Peterson, A. L., Manivannan, J., Rogers, E. S., Pchelintsev, N. A., Adams, P. D., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00666.x · Cited by 152
Histone H3.3 and its proteolytically processed form drive a cellular senescence programme
Duarte, L. F., Young, A. R. J., Wang, Z., Wu, H.-A., Panda, T., Kou, Y., Kapoor, A., Hasson, D., Mills, N. R., Ma’ayan, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6210 · Cited by 152
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 175
Cell cycle restriction by histone H2AX limits proliferation of adult neural stem cells
Fernando, R. N., Eleuteri, B., Abdelhady, S., Nussenzweig, A., Andäng, M., & Ernfors, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014993108 · Cited by 142
“, replicative cellular senescence, at least during transformation induced by oncogene activation (42, 43).”
BackgroundCellular senescence in musculoskeletal homeostasis, diseases, and regeneration
Wan, M., Gray-Gaillard, E. F., & Elisseeff, J. H. (2021) · Bone Research · doi:10.1038/s41413-021-00164-y · Cited by 165
Bianco, J. N., Bergoglio, V., Lin, Y., Pillaire, M., Schmitz, A.-L., Gilhodes, J., Lusque, A., Mazières, J., Lacroix‐Triki, M., Roumeliotis, T. I., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08886-8 · Cited by 160
Notch Signaling Mediates Secondary Senescence
Teo, Y. V., Rattanavirotkul, N., Olova, N., Salzano, A., Quintanilla, A., Tarrats, N., Kiourtis, C., Müller, M., Green, A. R., Adams, P. D., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.104 · Cited by 149
Cellular Senescence as the Causal Nexus of Aging
Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 146
The ATR barrier to replication-born DNA damage
López-Contreras, A. J., & Fernandez-Capetillo, O. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.012 · Cited by 139
Epigenetic clock analyses of cellular senescence and ageing.
Lowe, D., Horvath, S., & Raj, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7383 · Cited by 147
“Similarly, ectopic expression of oncogene causes aberrant re-initiation of DNA replication, the products of which are sensed by the cell as damaged DNA [21, 22].”
BackgroundGenomic instability in induced stem cells
Pasi, C. E., Dereli-Öz, A., Negrini, S., Friedli, M., Fragola, G., Lombardo, A., Van Houwe, G., Naldini, L., Casola, S., Testa, G., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.9 · Cited by 146
SCF E3 Ubiquitin Ligases as Anticancer Targets
Jia, L., & Sun, Y. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519734 · Cited by 164
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Sanjiv, K., Hagenkort, A., Calderón‐Montaño, J. M., Koolmeister, T., Reaper, P. M., Mortusewicz, O., Jacques, S. A., Kuiper, R., Schultz, N., Scobie, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.032 · Cited by 156
Pateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 156
“In aged mice, H-Ras activation resulted in a neoplastic phenotype that correlated with senescence, most probably via DDR/R activation (Di Micco et al., 2006; Gorgoulis et al., 2006; Gorgoulis et al., 2010), and an ImmR that was more extensive than in young mice, in addition to delayed tissue…”
BackgroundSecher, T., Samba-Louaka, A., Oswald, E., & Nougayrède, J.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077157 · Cited by 132
“In addition, persistent activation of DDR signalling is now commonly regarded as the mechanism triggering cellular senescence [6], suggesting that infection with E. coli producing colibactin could induce cellular senescence.”
SOCS1 Links Cytokine Signaling to p53 and Senescence
Calabrese, V., Mallette, F. A., Deschênes‐Simard, X., Ramanathan, S., Gagnon, J., Moores, A., Ilangumaran, S., & Ferbeyre, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.044 · Cited by 159
“…ATM and 754 Molecular Cell 36, 754–767, December 11, 2009 ª2009 Elsevier ATR play an essential role in p53 activation, indicating that the DNA damage response links oncogenic activity to the tumor suppression functions of p53 (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007a).”
BackgroundFrancia, S., Cabrini, M., Matti, V., Oldani, A., & d'Adda di Fagagna, F. (2016) · Journal of Cell Science · doi:10.1242/jcs.182188 · Cited by 141
“Staining for NBS1, MDC1, 53BP1, γH2AX and BrdU were performed as described previously (Di Micco et al., 2006).”
MethodMC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144
The role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?
Goehe, R. W., Di, X. M., Sharma, K., Bristol, M. L., Henderson, S. C., Valerie, K. C., Rodier, F., Davalos, A. R., & Gewirtz, D. A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197590 · Cited by 154
Derry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 140
Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling
Gagné, L. M., Boulay, K., Topisirović, I., Huot, M., & Mallette, F. A. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.002 · Cited by 152
Human Ageing Genomic Resources: updates on key databases in ageing research
de Magalhães, J. P., Abidi, Z., dos Santos, G. A., Avelar, R. A., Barardo, D., Chatsirisupachai, K., Clark, P. A., De‐Souza, E. A., Johnson, E. J., Lopes, I., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad927 · Cited by 172
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Patel, P. L., Suram, A., Mirani, N., Bischof, O., & Herbig, U. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602379113 · Cited by 142
“The ensuing DNA damage response (DDR) triggers OIS, thereby arresting cells within a few cell-division cycles after oncogene expression (8, 9).”
BackgroundUpdate on Human Polyomaviruses and Cancer
Gjoerup, O. V., & Chang, Y. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06001-x · Cited by 160
Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 135
“Given the recent finding that oncogenic stress activates the DNA damage response (Bartkova et al., 2006; Di Micco et al., 2006), formation of the transcriptionally active pRB-E2F1 complexes may be further reinforced through E1A’s activation of the DNA damage-dependent process.”
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
Chuang, L. S. H., & Ito, Y. (2010) · Oncogene · doi:10.1038/onc.2010.88 · Cited by 149
Oncogene-Induced Senescence Pathways Weave an Intricate Tapestry
Yaswen, P., & Campisi, J. (2007) · Cell · doi:10.1016/j.cell.2007.01.005 · Cited by 154
“Recent findings show that these oncogenes cause Micco et al., 2006; Mallette et al., 2007).”
BackgroundRau, R. E., & Brown, P. A. (2009) · Hematological Oncology · doi:10.1002/hon.904 · Cited by 155
The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation
Nicholson, T. B., Chen, T., & Richard, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.006 · Cited by 159
Heiss, E. H., Schilder, Y. D. C., & Dirsch, V. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703229200 · Cited by 136
Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140
“sensitivity to nutlin likely reflects a cooperative effect between the drug and oncogenic Ras, the latter known to activate p53 by multiple pathways including the generation of DNA damage (47, 48).”
BackgroundReplication fork dynamics and the DNA damage response
Jones, R. M., & Petermann, E. (2012) · Biochemical Journal · doi:10.1042/bj20112100 · Cited by 160
Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7γ
Bonetti, P., Davoli, T., Sironi, C., Amati, B. B., Pelicci, P. G., & Colombo, E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711040 · Cited by 141
Cellular senescence, ageing and disease
Burton, D. G. A. (2008) · AGE · doi:10.1007/s11357-008-9075-y · Cited by 160
Senescent cells communicate via intercellular protein transfer
Biran, A., Perelmutter, M., Gal, H., Burton, D. G. A., Ovadya, Y., Vadai, E., Geiger, T., & Krizhanovsky, V. (2015) · Genes & Development · doi:10.1101/gad.259341.115 · Cited by 139
Chromothripsis: Chromosomes in Crisis
Jones, M. J. K., & Jallepalli, P. V. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.10.010 · Cited by 130
“…check by Rb and other pocket proteins (e.g., Cdc6 and cyclin E) can induce both replication stress and S phasespecific DSBs in primary cells (Bartkova et al., 2006; Di Micco et al., 2006), possibly through precocious origin firing and accelerated depletion of nucleotide pools (Bester et al., 2011).”
BackgroundAURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Bertran-Alamillo, J., Cattan, V., Schoumacher, M., Codony-Servat, J., Giménez-Capitán, A., Cantero, F., Burbridge, M., Rodríguez, S., Teixidó, C., Roman, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09734-5 · Cited by 138
Epigenetic Regulation of Cellular Senescence
Crouch, J., Shvedova, M., Thanapaul, R. J. R. S., Botchkarev, V., & Roh, D. (2022) · Cells · doi:10.3390/cells11040672 · Cited by 126
“In addition to replicative senescence, senescence may be induced via aberrant activation of oncogenes such as BRAFV600E or RAS, which mediate cell proliferation and are known drivers of tumor progression and metastasis [10,11].”
BackgroundKrizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.048 · Cited by 138
“The nature of this signal is the topic of much debate and likely involves activation of the INK4a/ARF locus as well as a DNA-damage response through signals produced by replication stress (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundRai, P., Young, J. J., Burton, D. G. A., Giribaldi, M. G., Önder, T. T., & Weinberg, R. A. (2010) · Oncogene · doi:10.1038/onc.2010.520 · Cited by 141
Cellular senescence and cancer chemotherapy resistance
Gordon, R. R., & Nelson, P. S. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.002 · Cited by 134
“Additionally, in certain situations overexpression of oncogenes can lead to hyper proliferation and as a result, activation of the cellular senescence response (Di Micco et al., 2006).”
BackgroundElevated Local Senescence in Diabetic Wound Healing Is Linked to Pathological Repair via CXCR2
Wilkinson, H. N., Clowes, C., Banyard, K. L., Matteuci, P., Mace, K. A., & Hardman, M. J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.005 · Cited by 135
Putting the brakes on the cell cycle: mechanisms of cellular growth arrest
Pack, L. R., Daigh, L. H., & Meyer, T. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.05.005 · Cited by 143
“An extensive number of stimuli have been reported to trigger cellular senescence: oncogene activation [42,43], ionizing radiation and other DNA damaging agents, mitochondrial dysfunction [44,45], chromatin alterations [46–48], and impairment of ribosome biogenesis [49,50], for example.”
BackgroundOur Conflict with Transposable Elements and Its Implications for Human Disease
Burns, K. H. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032633 · Cited by 137
Takeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., Hirao, A., Yanagi, S., Fukami, K., Ishikawa, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0801 · Cited by 136
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
Abe, Y., Oda-Sato, E., Tobiume, K., Kawauchi, K., Taya, Y., Okamoto, K., Oren, M., & Tanaka, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712216105 · Cited by 136
“Recent studies have clearly shown that oncogene activation evokes a DNA-damage response, which results in p53 activation (12, 13).”
BackgroundInfluentialMechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
Lee, J.-K., Choi, Y.-L., Kwon, M., & Park, P. J. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044446 · Cited by 135
Replication stress and cancer: It takes two to tango
Lecona, E., & Fernández-Capetillo, O. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.019 · Cited by 132
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W., & McArthur, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.358 · Cited by 133
Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2007) · Genes & Development · doi:10.1101/gad.1586007 · Cited by 132
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundDNA replication stress and cancer chemotherapy
Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13455 · Cited by 146
“As induction of DRS appears to be a common event during tumorigenesis, most malignant tumor cells are thought to survive in the presence of severe DRS. Exploiting DRS is a prospective strategy for cancer therapy.17 To develop novel cancer therapeutic regimens that maximize antitumor effects and minimize adverse effect…”
BackgroundInfluential
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.